Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170,403,883
-
Total 13F shares
-
31,705,460
-
Share change
-
-299,574
-
Total reported value
-
$143,306,876
-
Price per share
-
$4.52
-
Number of holders
-
63
-
Value change
-
-$2,231,121
-
Number of buys
-
24
-
Number of sells
-
30
Institutional Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q4 2018
As of 31 Dec 2018,
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) was held by
63 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,705,460 shares.
The largest 10 holders included
Flagship Pioneering Inc., FMR LLC, ARK Investment Management LLC, BlackRock Inc., FEDERATED INVESTORS INC /PA/, Vanguard Group Inc, RENAISSANCE TECHNOLOGIES LLC, JPMORGAN CHASE & CO, STATE STREET CORP, and D. E. Shaw & Co., Inc..
This page lists
63
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.